| The costs and effectiveness of four HIV counseling and testing strategies in Uganda. | |
| | |
MedLine Citation:
|
PMID: 19114865 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: HIV counseling and testing (HCT) is a key intervention for HIV/AIDS control, and new strategies have been developed for expanding coverage in developing countries. We compared costs and outcomes of four HCT strategies in Uganda. DESIGN: A retrospective cohort of 84 323 individuals received HCT at one of four Ugandan HCT programs between June 2003 and September 2005. HCT strategies assessed were stand-alone HCT; hospital-based HCT; household-member HCT; and door-to-door HCT. METHODS: We collected data on client volume, demographics, prior testing and HIV diagnosis from project monitoring systems, and cost data from project accounts and personnel interviews. Strategies were compared in terms of costs and effectiveness at reaching key population groups. RESULTS: Household-member and door-to-door HCT strategies reached the largest proportion of previously untested individuals (>90% of all clients). Hospital-based HCT diagnosed the greatest proportion of HIV-infected individuals (27% prevalence), followed by stand-alone HCT (19%). Household-member HCT identified the highest percentage of discordant couples; however, this was a small fraction of total clients (<4%). Costs per client (2007 USD) were $19.26 for stand-alone HCT, $11.68 for hospital-based HCT, $13.85 for household-member HCT, and $8.29 for door-to-door-HCT. CONCLUSION: All testing strategies had relatively low per client costs. Hospital-based HCT most readily identified HIV-infected individuals eligible for treatment, whereas home-based strategies more efficiently reached populations with low rates of prior testing and HIV-infected people with higher CD4 cell counts. Multiple HCT strategies with different costs and efficiencies can be used to meet the UNAIDS/WHO call for universal HCT access by 2010. |
| | |
Authors:
|
Nick Menzies; Betty Abang; Rhoda Wanyenze; Fred Nuwaha; Balaam Mugisha; Alex Coutinho; Rebecca Bunnell; Jonathan Mermin; John M Blandford |
Related Documents
:
|
3953595 - Microcosting method for small-volume injectables. 10300165 - Medicare program; schedule of limits on home health agency costs per visit for cost rep... 10538175 - Costing of a cardiac catheterisation procedure. 11271445 - Accounting for a not-for-profit organization's fund-raising costs. 20498735 - Impact of previous pharmacy work experience on pharmacy school academic performance. 17087445 - Improving mathematics teaching and learning experiences for hard of hearing students wi... |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: AIDS (London, England) Volume: 23 ISSN: 1473-5571 ISO Abbreviation: AIDS Publication Date: 2009 Jan |
Date Detail:
|
Created Date: 2009-02-03 Completed Date: 2009-04-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8710219 Medline TA: AIDS Country: England |
Other Details:
|
Languages: eng Pagination: 395-401 Citation Subset: IM; X |
Affiliation:
|
US Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Atlanta, Georgia, USA. nmenzies@fas.harvard.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
AIDS Serodiagnosis
/
economics*,
methods Adolescent Adult Age Distribution Child Child, Preschool Cost-Benefit Analysis Counseling / economics*, organization & administration Delivery of Health Care / economics*, organization & administration Developing Countries Female HIV Infections / diagnosis*, economics, prevention & control Health Care Costs / statistics & numerical data Health Services Research / methods Humans Infant Infant, Newborn Male Middle Aged Retrospective Studies Uganda Young Adult |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.
Next Document: Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.